Dr. Denise Scots-Knight

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

MREO

Current role

CEO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Mereo BioPharma Group plc (MREO)	Chief Executive Officer	$565,107	$254,298	$285,358	$1,043,403	—	$71,157	$2,219,323
2022	Mereo BioPharma Group plc (MREO)	Chief Executive Officer	$506,809	$304,085	—	$1,358,134	—	$68,219	$2,237,247

No earnings-call appearances or filed executive changes recorded yet.